Akebia Therapeutics
AKBA
#7690
Rank
S$0.47 B
Marketcap
S$1.80
Share price
-7.89%
Change (1 day)
-29.76%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: S$0.47 Billion

As of January 2026 Akebia Therapeutics has a market cap of S$0.47 Billion. This makes Akebia Therapeutics the world's 7690th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.47 B-15.49%
2025S$0.56 B-2.2%
2024S$0.57 B87.45%
2023S$0.30 B116.81%
2022S$0.14 B-73.38%
2021S$0.53 B-0.16%
2020S$0.53 B-48.36%
2019S$1.03 B17.4%
2018S$0.88 B-6.07%
2017S$0.94 B62.82%
2016S$0.57 B3.04%
2015S$0.56 B78.86%
2014S$0.31 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Akebia Therapeutics was reported to be:

S$0.47 Billion
by Nasdaq info icon info icon
S$0.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
S$225.53 B 47,084.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$350.11 B 73,147.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
S$650.08 B 135,905.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S$1.01 B 112.28%๐Ÿ‡บ๐Ÿ‡ธ USA